VUNO Med-BoneAge
Commercial- Indications
- Bone age assessment
Company intelligence / Profile preview
VUNO
Seoul, South Koreavuno.co ↗
- Ownership
- Private
- Employees
- ~104
- Development stage
- Commercial
01
Overview
VUNO has developed several MFDS-approved and FDA-cleared AI-driven diagnostic support tools. Clinical studies have demonstrated high accuracy in cardiac arrest prediction using real-world data across multiple hospitals. Their brain volumetry tool for Alzheimer’s diagnosis received FDA clearance in October 2023. The chest X-ray solution was recently approved for expanded use in Korea after demonstrating safety and utility in clinical settings.
- Therapeutic areas
- PulmonologyEndocrinologyCardiovascularOphthalmologyNeurology
- Modalities
- DeviceSoftware (AI-based medical imaging and biosignal analysis)Digital pathology
- Industry
- Digital Health Medical Devices
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Mayo Clinic – collaboration on AI R&D and clinical validation projectsMultiple Korean tertiary hospitals – multicenter studies on cardiac risk predictionCollaborations with pharmaceutical/biotech companies targeting internal medicine/checkup centers through eye care product partnerships
Beyond the preview
Go deeper on VUNO.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on VUNO.